Cargando…

Individualizing the use of [(18)F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteremia: experiences from a tertiary care center

PURPOSE: [(18)F]FDG-PET/CT scanning can help detect metastatic infectious foci and reduce mortality in patients with Staphylococcus aureus bacteremia (SAB), but it is unknown if patients with SAB and an indication for prolonged treatment because of possible endovascular, orthopaedic implant, or othe...

Descripción completa

Detalles Bibliográficos
Autores principales: van Leerdam, Eline J., Gompelman, Michelle, Tuinte, Renée A. M., Aarntzen, Erik H. J. G., Berrevoets, Marvin A. H., Maat, Ianthe, Bleeker-Rovers, Chantal P., van Crevel, Reinout, ten Oever, Jaap, Kouijzer, Ilse J. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942890/
https://www.ncbi.nlm.nih.gov/pubmed/34928493
http://dx.doi.org/10.1007/s15010-021-01740-4
_version_ 1784673402613661696
author van Leerdam, Eline J.
Gompelman, Michelle
Tuinte, Renée A. M.
Aarntzen, Erik H. J. G.
Berrevoets, Marvin A. H.
Maat, Ianthe
Bleeker-Rovers, Chantal P.
van Crevel, Reinout
ten Oever, Jaap
Kouijzer, Ilse J. E.
author_facet van Leerdam, Eline J.
Gompelman, Michelle
Tuinte, Renée A. M.
Aarntzen, Erik H. J. G.
Berrevoets, Marvin A. H.
Maat, Ianthe
Bleeker-Rovers, Chantal P.
van Crevel, Reinout
ten Oever, Jaap
Kouijzer, Ilse J. E.
author_sort van Leerdam, Eline J.
collection PubMed
description PURPOSE: [(18)F]FDG-PET/CT scanning can help detect metastatic infectious foci and reduce mortality in patients with Staphylococcus aureus bacteremia (SAB), but it is unknown if patients with SAB and an indication for prolonged treatment because of possible endovascular, orthopaedic implant, or other metastatic infection still need [(18)F]FDG-PET/CT. METHODS: In a retrospective single-center cohort study, we included all consecutive adult patients with SAB between 2013 and 2020 if an [(18)F]FDG-PET/CT scan was performed and antibiotic treatment was planned for ≥ 6 weeks prior to [(18)F]FDG-PET/CT. We aimed to identify patients for whom treatment was adjusted due to the results of [(18)F]FDG-PET/CT, and assessed concordance of [(18)F]FDG-PET/CT and clinical diagnosis for infected prosthetic material. RESULTS: Among 132 patients included, the original treatment plan was changed after [(18)F]FDG-PET/CT in 22 patients (16.7%), in the majority (n = 20) due to diagnosing or rejecting endovascular (graft) infection. Antibiotic treatment modifications were shortening in 2, iv-oral switch in 3, extension in 13, and addition of rifampicin in 4 patients. Ninety additional metastatic foci based on [(18)F]FDG-PET/CT results were found in 69/132 patients (52.3%). [(18)F]FDG-PET/CT suggested vascular graft infection in 7/14 patients who lacked clinical signs of infection, but showed no infection of prosthetic joints or osteosynthesis material in eight patients who lacked clinical signs of such an infection. CONCLUSION: [(18)F]FDG-PET/CT can help refine treatment for SAB in patients with clinically suspected endovascular infection or vascular grafts, even if 6 weeks treatment is already indicated, but can be safely omitted in other patients who are clinically stable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-021-01740-4.
format Online
Article
Text
id pubmed-8942890
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89428902022-04-07 Individualizing the use of [(18)F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteremia: experiences from a tertiary care center van Leerdam, Eline J. Gompelman, Michelle Tuinte, Renée A. M. Aarntzen, Erik H. J. G. Berrevoets, Marvin A. H. Maat, Ianthe Bleeker-Rovers, Chantal P. van Crevel, Reinout ten Oever, Jaap Kouijzer, Ilse J. E. Infection Original Paper PURPOSE: [(18)F]FDG-PET/CT scanning can help detect metastatic infectious foci and reduce mortality in patients with Staphylococcus aureus bacteremia (SAB), but it is unknown if patients with SAB and an indication for prolonged treatment because of possible endovascular, orthopaedic implant, or other metastatic infection still need [(18)F]FDG-PET/CT. METHODS: In a retrospective single-center cohort study, we included all consecutive adult patients with SAB between 2013 and 2020 if an [(18)F]FDG-PET/CT scan was performed and antibiotic treatment was planned for ≥ 6 weeks prior to [(18)F]FDG-PET/CT. We aimed to identify patients for whom treatment was adjusted due to the results of [(18)F]FDG-PET/CT, and assessed concordance of [(18)F]FDG-PET/CT and clinical diagnosis for infected prosthetic material. RESULTS: Among 132 patients included, the original treatment plan was changed after [(18)F]FDG-PET/CT in 22 patients (16.7%), in the majority (n = 20) due to diagnosing or rejecting endovascular (graft) infection. Antibiotic treatment modifications were shortening in 2, iv-oral switch in 3, extension in 13, and addition of rifampicin in 4 patients. Ninety additional metastatic foci based on [(18)F]FDG-PET/CT results were found in 69/132 patients (52.3%). [(18)F]FDG-PET/CT suggested vascular graft infection in 7/14 patients who lacked clinical signs of infection, but showed no infection of prosthetic joints or osteosynthesis material in eight patients who lacked clinical signs of such an infection. CONCLUSION: [(18)F]FDG-PET/CT can help refine treatment for SAB in patients with clinically suspected endovascular infection or vascular grafts, even if 6 weeks treatment is already indicated, but can be safely omitted in other patients who are clinically stable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-021-01740-4. Springer Berlin Heidelberg 2021-12-20 2022 /pmc/articles/PMC8942890/ /pubmed/34928493 http://dx.doi.org/10.1007/s15010-021-01740-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
van Leerdam, Eline J.
Gompelman, Michelle
Tuinte, Renée A. M.
Aarntzen, Erik H. J. G.
Berrevoets, Marvin A. H.
Maat, Ianthe
Bleeker-Rovers, Chantal P.
van Crevel, Reinout
ten Oever, Jaap
Kouijzer, Ilse J. E.
Individualizing the use of [(18)F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteremia: experiences from a tertiary care center
title Individualizing the use of [(18)F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteremia: experiences from a tertiary care center
title_full Individualizing the use of [(18)F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteremia: experiences from a tertiary care center
title_fullStr Individualizing the use of [(18)F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteremia: experiences from a tertiary care center
title_full_unstemmed Individualizing the use of [(18)F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteremia: experiences from a tertiary care center
title_short Individualizing the use of [(18)F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteremia: experiences from a tertiary care center
title_sort individualizing the use of [(18)f]fdg-pet/ct in patients with complicated staphylococcus aureus bacteremia: experiences from a tertiary care center
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942890/
https://www.ncbi.nlm.nih.gov/pubmed/34928493
http://dx.doi.org/10.1007/s15010-021-01740-4
work_keys_str_mv AT vanleerdamelinej individualizingtheuseof18ffdgpetctinpatientswithcomplicatedstaphylococcusaureusbacteremiaexperiencesfromatertiarycarecenter
AT gompelmanmichelle individualizingtheuseof18ffdgpetctinpatientswithcomplicatedstaphylococcusaureusbacteremiaexperiencesfromatertiarycarecenter
AT tuintereneeam individualizingtheuseof18ffdgpetctinpatientswithcomplicatedstaphylococcusaureusbacteremiaexperiencesfromatertiarycarecenter
AT aarntzenerikhjg individualizingtheuseof18ffdgpetctinpatientswithcomplicatedstaphylococcusaureusbacteremiaexperiencesfromatertiarycarecenter
AT berrevoetsmarvinah individualizingtheuseof18ffdgpetctinpatientswithcomplicatedstaphylococcusaureusbacteremiaexperiencesfromatertiarycarecenter
AT maatianthe individualizingtheuseof18ffdgpetctinpatientswithcomplicatedstaphylococcusaureusbacteremiaexperiencesfromatertiarycarecenter
AT bleekerroverschantalp individualizingtheuseof18ffdgpetctinpatientswithcomplicatedstaphylococcusaureusbacteremiaexperiencesfromatertiarycarecenter
AT vancrevelreinout individualizingtheuseof18ffdgpetctinpatientswithcomplicatedstaphylococcusaureusbacteremiaexperiencesfromatertiarycarecenter
AT tenoeverjaap individualizingtheuseof18ffdgpetctinpatientswithcomplicatedstaphylococcusaureusbacteremiaexperiencesfromatertiarycarecenter
AT kouijzerilseje individualizingtheuseof18ffdgpetctinpatientswithcomplicatedstaphylococcusaureusbacteremiaexperiencesfromatertiarycarecenter